Skip to content

The Effect of Personalized Shoe Insole on the Gait of Parkinson's Disease Subjects

The Effect of Personalized Shoe Insole on the Gait of Parkinson's Disease Subjects: A Triple-blind Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04803565
Acronym
InsolePD
Enrollment
42
Registered
2021-03-17
Start date
2021-03-04
Completion date
2023-03-30
Last updated
2023-10-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson Disease

Keywords

Parkinson Disease, Foot Orthoses, Randomized controlled trial

Brief summary

This study aims to assess the efficacy of custom-made shoe insoles, for subjects with Parkinson's Disease (PD). To do that, a sample of PD subjects has been randomly assigned to an intervention group that will receive the custom-made insoles or a control group that will receive a sham insole without any specific manufacturing. Both groups will receive Physiotherapy and Occupational Therapy according to PD rehabilitation guidelines. The principal outcome will be the Time Up&Go test time, secondary outcomes 10 Meters Walking test speed, Berg Balance Scale score, SF12 score, and orthesis liking.

Interventions

DEVICECustom-made shoe insole

Subjects will receive a custom-made shoe insole designed on the patient's foot and shoes. The subjects should wear the insole for at least 6 hours per day.

DEVICESham conventional Insole

Subjects will receive a conventional insole without any specific property (sham insole)

Sponsors

Fondazione Don Carlo Gnocchi Onlus
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Subjects with Idiopathic Parkinson's Disease; * Age \> 18 years; * Subjects should be in a positive therapeutic window or in the ON phase during the evaluations; * Subjects must be able to walk at least 10 meters independently with or without any walking aid.

Exclusion criteria

* Not clinical stable subjects; * SUbjects in OFF phase during the evaluations; * Other neurological conditions (e.g. stroke, peripheral neuropathies, etc.); * Other pathologies that can negatively influence the subject's walking ability (e.g. surgery at the lower limbs in the previous 6 months, important deformities at the lower limbs, etc.)

Design outcomes

Primary

MeasureTime frameDescription
Change in Time Up&Go testBaseline, at 10 weeks, and at 16 weeks.Change from Baseline (without insoles (T0) and with insoles (T1)) Time Up&Go at 10 weeks (end of outpatient rehabilitation (T2)) and 16 weeks (follow-up (T3))

Secondary

MeasureTime frameDescription
Change in Berg Balance Scale ScoreBaseline, at 10 weeks, and at 16 weeks.Change from Baseline (without insoles (T0) and with insoles (T1)) Berg Balance Scale score at 10 weeks (end of outpatient rehabilitation (T2)) and 16 weeks (follow-up (T3))
Change in Short-Form12 scoreBaseline, at 10 weeks, and at 16 weeks.Change from Baseline Short-form 12 at 10 weeks (end of outpatient rehabilitation (T2)) and 16 weeks (follow-up (T3))
Change in Likert scale 4 pointsBaseline, at 10 weeks, and at 16 weeks.Change from Baseline Short-form 12 at 10 weeks (end of outpatient rehabilitation (T2)) and 16 weeks (follow-up (T3))
Change in 10 Meters Walking Test cadenceBaseline, at 10 weeks, and at 16 weeks.Change from Baseline (without insoles (T0) and with insoles (T1)) Kinematic parameters of gait during 10 Meters Walking test at 10 weeks (end of outpatient rehabilitation (T2)) and 16 weeks (follow-up (T3))
Change in 10 Meters Walking Test step lengthBaseline, at 10 weeks, and at 16 weeks.Change from Baseline (without insoles (T0) and with insoles (T1)) Kinematic parameters of gait during 10 Meters Walking test at 10 weeks (end of outpatient rehabilitation (T2)) and 16 weeks (follow-up (T3))
Change in 10 Meters Walking Test step durationBaseline, at 10 weeks, and at 16 weeks.Change from Baseline (without insoles (T0) and with insoles (T1)) Kinematic parameters of gait during 10 Meters Walking test at 10 weeks (end of outpatient rehabilitation (T2)) and 16 weeks (follow-up (T3))
Change in 10 Meters Walking Test stance phaseBaseline, at 10 weeks, and at 16 weeks.Change from Baseline (without insoles (T0) and with insoles (T1)) Kinematic parameters of gait during 10 Meters Walking test at 10 weeks (end of outpatient rehabilitation (T2)) and 16 weeks (follow-up (T3))
Change in 10 Meters walking test SpeedBaseline, at 10 weeks, and at 16 weeks.Change from Baseline (without insoles (T0) and with insoles (T1)) 10 Meters walking test speed at 10 weeks (end of outpatient rehabilitation (T2)) and 16 weeks (follow-up (T3))
Change in 10 Meters Walking Test single support phaseBaseline, at 10 weeks, and at 16 weeks.Change from Baseline (without insoles (T0) and with insoles (T1)) Kinematic parameters of gait during 10 Meters Walking test at 10 weeks (end of outpatient rehabilitation (T2)) and 16 weeks (follow-up (T3))
Change in 10 Meters Walking Test double support phaseBaseline, at 10 weeks, and at 16 weeks.Change from Baseline (without insoles (T0) and with insoles (T1)) Kinematic parameters of gait during 10 Meters Walking test at 10 weeks (end of outpatient rehabilitation (T2)) and 16 weeks (follow-up (T3))
Change in Time Up&Go test sit-to-stand timeBaseline, at 10 weeks, and at 16 weeks.Change from Baseline (without insoles (T0) and with insoles (T1)) Temporal and kinematic parameters of Time Up&Go test at 10 weeks (end of outpatient rehabilitation (T2)) and 16 weeks (follow-up (T3))
Change in Time Up&Go test stand-to-sit timeBaseline, at 10 weeks, and at 16 weeks.Change from Baseline (without insoles (T0) and with insoles (T1)) Temporal and kinematic parameters of Time Up&Go test at 10 weeks (end of outpatient rehabilitation (T2)) and 16 weeks (follow-up (T3))
Change in Time Up&Go test mid-turning timeBaseline, at 10 weeks, and at 16 weeks.Change from Baseline (without insoles (T0) and with insoles (T1)) Temporal and kinematic parameters of Time Up&Go test at 10 weeks (end of outpatient rehabilitation (T2)) and 16 weeks (follow-up (T3))
Change in Time Up&Go test end-turning timeBaseline, at 10 weeks, and at 16 weeks.Change from Baseline (without insoles (T0) and with insoles (T1)) Temporal and kinematic parameters of Time Up&Go test at 10 weeks (end of outpatient rehabilitation (T2)) and 16 weeks (follow-up (T3))
Change in 10 Meters Walking Test swing phaseBaseline, at 10 weeks, and at 16 weeks.Change from Baseline (without insoles (T0) and with insoles (T1)) Kinematic parameters of gait during 10 Meters Walking test at 10 weeks (end of outpatient rehabilitation (T2)) and 16 weeks (follow-up (T3))

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026